Back
Haemonetics Quote, Financials, Valuation and Earnings
Sponsored
HAE
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Buy
78
HAE
Haemonetics
Last Price:
92.17
Seasonality Move:
6.15%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Haemonetics Price Quote
$92.17
+0.22 (+0.24%)
(Updated: May 1, 2024 at 4:50 PM ET)
Haemonetics Key Stats
Buy
78
Haemonetics (HAE)
is a Buy
Day range:
$90.62 - $92.15
52-week range:
$70.74 - $95.26
Dividend yield:
0%
P/E ratio:
41.05
P/S ratio:
3.72
P/B ratio:
4.95%
Volume:
547.8K
Avg. volume:
448K
1-year change:
9.84%
Market cap:
$4.7B
Revenue:
$1.2B
EPS:
$2.46
How Much Does Haemonetics Make?
-
How Much Are Haemonetics's Sales Annually?
HAE Revenues are $1.2B -
How Much Profit Does Haemonetics's Make A Year?
HAE net income is $115.4M
Is Haemonetics Growing As A Company?
-
What Is Haemonetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is Haemonetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.05%
Haemonetics Stock Price Performance
-
Did Haemonetics Stock Go Up Last Month?
Haemonetics share price went up by 7.73% last month -
Did HAE's Share Price Rise Over The Last Year?
HAE share price rose by 9.84% over the past 1 year
What Is Haemonetics 52-Week High & Low?
-
What Is Haemonetics’s 52-Week High Share Price?
Haemonetics has traded as high as $95.26 over the past 52 weeks -
What Is Haemonetics’s 52-Week Low Share Price?
Haemonetics has traded as low as $70.74 over the past 52 weeks
Haemonetics Price To Free Cash Flow
-
Is Haemonetics Stock Overvalued?
Haemonetics is trading at a price to free cash flow ratio of 36.67 -
Is Haemonetics Stock Undervalued?
Haemonetics EV to Free Cash Flow ratio is 41.53 -
What Is Haemonetics’s Price Earnings Growth Ratio?
HAE PEG ratio is 1.13 -
Is Haemonetics Trading At A Premium To Earnings?
Haemonetics EV to EBIT ratio is 31.41
Is It Risky To Buy Haemonetics?
-
How Much Debt Does Haemonetics Have?
Total long term debt quarterly is $870.6M -
How Much Cash Does Haemonetics Have?
Cash and short term investments quarterly total is $194M -
What Is Haemonetics’s Book Value Per Share?
Book value per share is 18.57
Is Haemonetics Cash Flow Positive?
-
What Is HAE Cash Flow From Operations?
Cash flow from operations (TTM) is $197.3M -
What Is Haemonetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $100.1M -
What Is Haemonetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$327.3M
Haemonetics Return On Invested Capital
-
Is Management Doing A Good Job?
HAE return on invested capital is 7.69% -
What Is Haemonetics Return On Assets?
ROA measures how assets are converting to revenues and is 6.34% -
What Is HAE Return On Equity?
ROE is a measure of profitability and is 14.73%
Haemonetics Earnings Date & Stock Price
-
What Is Haemonetics's Stock Price Today?
A single share of HAE can be purchased today for 91.95 -
What Is Haemonetics’s Stock Symbol?
Haemonetics trades on the nyse under the ticker symbol: HAE -
When Is Haemonetics’s Next Earnings Date?
The next quarterly earnings date for Haemonetics is scheduled on May 10, 2024 -
When Is HAE's next ex-dividend date?
Haemonetics's next ex-dividend date is May 1, 2024 -
How To Buy Haemonetics Stock?
You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Haemonetics Competitors
-
Who Are Haemonetics's Competitors?
Below is a list of companies who compete with Haemonetics or are related in some way:
Haemonetics Dividend Yield
Data Unavailable
Haemonetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -4.69% | 10.46% |
Revenue: | 10.14% | 4.83% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 107.17 |
Upside from Last Price: | 16.55% |